Literature DB >> 2887244

Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum.

R J Ferrante, N W Kowall.   

Abstract

Tyrosine hydroxylase-like immunoreactivity (TH-lir) was examined in the adult human neostriatum and found to be heterogeneously distributed. Comparison of TH-lir with adjacent sections stained for acetylcholinesterase (AChE) activity showed that TH-lir is confined to the AChE-rich matrix compartment. TH-lir persists within the matrix zone, which is reduced in Huntington's disease (HD), suggesting that the nigrostriatal AChE projection may contribute to the persistent AChE patch-matrix pattern in HD. Despite marked striatal atrophy, the density of TH-immunoreactive fibers and terminals remained unchanged. This represents a loss of TH-positive extrinsic afferents in HD proportionate to striatal atrophy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887244     DOI: 10.1016/0006-8993(87)91506-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

Authors:  A M Graybiel; R Moratalla
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

3.  Compartmentalization of excitatory amino acid receptors in human striatum.

Authors:  L S Dure; A B Young; J B Penney
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 4.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

Review 5.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

6.  Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey.

Authors:  L S Forno; L E DeLanney; I Irwin; J W Langston
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 7.  Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.

Authors:  Ryoma Morigaki; Satoshi Goto
Journal:  Brain Sci       Date:  2017-06-07

8.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

9.  Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum.

Authors:  Ryoma Morigaki; Satoshi Goto
Journal:  Front Neuroanat       Date:  2016-04-05       Impact factor: 3.856

Review 10.  Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.

Authors:  Susanna Waters; Joakim Tedroff; Henrik Ponten; Daniel Klamer; Clas Sonesson; Nicholas Waters
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.